Intelesens is a highly innovative medical technology company selling the world's first intelligent, non-invasive, wireless vital signs monitoring device for use in remote patient monitoring telehealth applications. It is a spin-out of the University of Ulster and is funded via venture capital investment. The Company has assembled a world-class team of employees that have quickly established Intelesens at the forefront of exciting developments in the growing remote patient monitoring market.